What does HER2 status mean for Multiple Myeloma treatment

Multiple MyelomaMay 18, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

HER2 Status and Multiple Myeloma: Important Clarification

I appreciate this question because it highlights an important distinction in cancer care. HER2 status is NOT typically relevant for multiple myeloma treatment planning.

Here's why:

HER2 Testing in Different Cancers

HER2 (human epidermal growth factor receptor 2) is a protein that's important in specific cancers, particularly:

  • Breast cancer - where HER2 testing is standard and guides treatment decisions
  • Gastric (stomach) cancer - where HER2 status helps determine therapy options
  • Some other solid tumors

According to NCCN Guidelines for breast cancer, HER2 testing determines whether patients benefit from HER2-targeted therapies like trastuzumab (Herceptin) or pertuzumab. However, multiple myeloma is a blood cancer with a completely different biology.

What Actually Matters for Myeloma Treatment

According to the NCCN Guidelines for Patients: Multiple Myeloma, the biomarkers that DO guide treatment decisions include:

  • Chromosomal abnormalities (detected by FISH testing) - such as deletions of chromosome 17, translocations involving chromosome 14, or amplification of chromosome 1q21
  • M protein type (IgG, IgA, IgM, kappa, or lambda)
  • Free light chain levels
  • Bone marrow involvement percentage

These findings help determine whether your myeloma is standard-risk or high-risk, which influences treatment intensity and approach.

Questions to Ask Your Myeloma Team

If you have multiple myeloma, consider asking:

  1. What is my specific cytogenetic risk profile? (This is what matters for myeloma)
  2. What is my M protein type and level?
  3. Have I had FISH testing to look for high-risk chromosomal changes?
  4. Based on these findings, what treatment approach do you recommend?

If you have a different cancer type (like breast cancer) AND myeloma, that would be unusual and would require specialized discussion with your care team about each cancer separately.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: